|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flow from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Loss on debt extinguishment | |||||
| Gain on change in fair value of financial derivatives and warrant liabilities | |||||
| Loss (gain) on change in fair value of financial liabilities | |||||
| Unrealized loss on digital asset | |||||
| Deferred tax benefit | |||||
| Loss on repayment of credit facility | |||||
| (Gain) loss on change in fair value of financial liabilities | |||||
| Noncash interest income on certificate of deposit | |||||
| Stock-based compensation | |||||
| Loss on write down of inventory and inventory deposits | |||||
| Loss on lease termination | |||||
| Loss on write-off of property & equipment | |||||
| Write-off of intangible assets | |||||
| Loss on sale/write off of property & equipment | |||||
| Bad debt expense | |||||
| Non-cash interest expense | |||||
| Amortization of right-of-use assets | |||||
| Depreciation and amortization | |||||
| Loss on repayment of May 2024 Notes | |||||
| Loss on extinguishment of convertible notes | |||||
| Loss on conversion of convertible notes to common stock | |||||
| Gain on exercise of Series B Warrants | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventory | |||||
| Inventory deposits | |||||
| Prepaid assets and other current assets | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accrued liabilities and vendor settlements | |||||
| Right-of-use liabilities - operating leases | |||||
| Customer deposits | |||||
| Net cash used in operating activities | |||||
| Cash flow from investing activities: | |||||
| Purchase of digital assets | |||||
| Proceeds paid for website development | |||||
| Purchase of property and equipment | |||||
| Proceeds from sale of property and equipment | |||||
| Proceeds from insurance settlement | |||||
| Proceeds from sale of vehicles | |||||
| Purchase of certificate of deposit | |||||
| Net cash used in investing activities | |||||
| Cash flow from financing activities: | |||||
| Repayment of notes payable | |||||
| Proceeds from issuance of common stock from public offerings, net of issuance costs of $629,900 | |||||
| Proceeds from issuance of common stock and pre-funded warrants from public offering, net of issuance costs of $1,210,753 | |||||
| Proceeds from exercise of Series B Warrants | |||||
| Proceeds from credit facility, net of issuance costs of $194,551 | |||||
| Repayment of credit facility | |||||
| Proceeds from term loan, net of issuance costs of $149,913 | |||||
| Proceeds from Credit facility, net of issuance costs of $62,804 | |||||
| Proceeds from issuance of common stock units and pre-funded warrant units from February 2025 public offering, net of issuance costs of $1,296,118 | |||||
| Proceeds from issuance of common stock and pre-funded warrants from July 2025 private placement, net of issuance costs of $21,136,401 | |||||
| Proceeds from exercise of buy down warrants | |||||
| Series B Warrants | |||||
| Buy Down Warrants | |||||
| Total proceeds from exercise of buy down warrants | |||||
| Proceeds from exercise of stock options | |||||
| Proceeds from the issuance of common stock issued from the At the Market Offering, net of issuance costs of $374,392 in 2025 and $112,814 in 2024 | |||||
| Proceeds from issuance of common stock from public offering, net of issuance costs of $629,900 | |||||
| Proceeds from issuance of convertible notes and warrants, net of issuance costs of $586,968 | |||||
| Proceeds from issuance of common stock units, net of issuance costs of $28,777 | |||||
| Proceeds from issuance of pre-funded warrant units, net of issuance costs of $342,071 | |||||
| Repurchase of common stock | |||||
| Repurchase of fractional shares | |||||
| Proceeds from issuance of common stock units and pre-funded warrant units from July 2024 public offering, net of issuance costs of $1,210,753 | |||||
| Repayment of May 2024 Notes | |||||
| Proceeds from issuance of May 2024 Notes and warrants, net of issuance costs of $245,150 | |||||
| Proceeds from reduction of exercise price of warrants | |||||
| Proceeds from issuance of common stock from public offering, net of issuance costs of $1,910,816 | |||||
| Proceeds from issuance of convertible notes, net of issuance costs of $2,312,895 | |||||
| Proceeds from issuance of warrants to convertible note holders, net of issuance costs of $1,003,513 | |||||
| Net cash provided by financing activities | |||||
| NET CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH | |||||
| CASH, CASH EQUIVALENTS AND RESTRICTED CASH AT BEGINNING OF PERIOD | |||||
| CASH, CASH EQUIVALENTS AND RESTRICTED CASH AT END OF PERIOD | |||||
| Supplemental disclosure of cash flow information: | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| Non-cash transactions: | |||||
| Recognition of initial right-of-use asset - operating lease | |||||
| Issuance of common stock for exercise of prefunded warrants | |||||
| Acquisition of property and equipment with note payable | |||||
| Reclassification of derivative liabilities to equity | |||||
| Issuance of common stock for digital assets | |||||
| Transfer of inventory to property & equipment | |||||
| Transfer of digital assets to lender for collateral | |||||
| Recognition of right of use asset and liability - operating lease | |||||
| Conversion of Convertible Notes for common stock | |||||
| Exchange of Convertible Notes for Preferred Stock | |||||
| Reclassification of warrant liability to equity for cashless exercise of Series A Warrants | |||||
| Reclassification of warrant liability to equity for modification of Series B Warrants | |||||
| Exchange of property & equipment in lieu of payments due for inventory purchases | |||||
| Exchange of finished goods inventory with vendor for raw materials inventory | |||||
| Conversion of preferred stock for common stock | |||||
| Issuance of common stock for exercise of pre-funded warrants | |||||
Loading...